Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WEAV
WEAV logo

WEAV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Weave Communications Inc (WEAV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
4.410
1 Day change
0.92%
52 Week Range
11.340
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Weave Communications Inc (WEAV) is not a strong buy at the moment for a beginner investor with a long-term focus. Despite some positive growth trends in revenue and gross margin, the negative financial performance, insider selling activity, and lack of strong technical or proprietary trading signals suggest that holding off on investment is prudent.

Technical Analysis

The technical indicators show a bearish trend. The MACD histogram is negative and contracting, RSI is neutral at 30.752, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 4.351, with resistance at 5.023.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • Gross margin improved significantly by 38.30% YoY, reaching 99.69%. Analysts highlight potential growth drivers in AI and specialty medical sectors.

Neutral/Negative Catalysts

  • Insider selling activity has increased by 108.69% over the last month. Analysts have lowered price targets recently, citing challenges in SMB software and deceleration in growth.

Financial Performance

In Q4 2025, revenue grew to $63.4M (up 17.05% YoY), but net income fell to -$1.85M (-72.46% YoY), and EPS dropped to -0.04 (-55.56% YoY). Gross margin improved to 99.69% (up 38.30% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain a generally positive long-term outlook but have lowered price targets recently. Stifel lowered the target to $9 (from $11) and Piper Sandler to $8 (from $12), both maintaining Buy/Overweight ratings. Raymond James downgraded the stock to Outperform from Strong Buy, citing timing challenges and the need for more visible growth re-acceleration.

Wall Street analysts forecast WEAV stock price to rise
4 Analyst Rating
Wall Street analysts forecast WEAV stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 4.370
sliders
Low
8
Averages
10.25
High
12
Current: 4.370
sliders
Low
8
Averages
10.25
High
12
Stifel
J. Parker Lane
Buy
downgrade
$11 -> $9
AI Analysis
2026-02-20
Reason
Stifel
J. Parker Lane
Price Target
$11 -> $9
AI Analysis
2026-02-20
downgrade
Buy
Reason
Stifel analyst J. Parker Lane lowered the firm's price target on Weave to $9 from $11 and keeps a Buy rating on the shares.
Piper Sandler
Overweight -> NULL
downgrade
$12 -> $8
2026-02-20
Reason
Piper Sandler
Price Target
$12 -> $8
2026-02-20
downgrade
Overweight -> NULL
Reason
Piper Sandler lowered the firm's price target on Weave to $8 from $12 and keeps an Overweight rating on the shares. The firm notes the company posted another quarter of 17% year-over-year growth, driven by payments, strong location additions, and the recent TrueLark acquisition. FY26 top-line growth guidance of 14.8% year-over-year came in roughly in-line with consensus expectations and implies a deceleration from the 17.0% growth in FY25, while operating income guidance implies 190 bps of operating margin expansion in the coming year. Looking ahead, Piper expects AI and specialty medical to be the biggest growth drivers in FY26.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for WEAV
Unlock Now

People Also Watch